Endocrine Abstracts

We have interviewed 246 people aged 18–55 years: 126 with DM type 2 with a duration of more than 5 years; 120 – without DM. The median body mass index (BMI) was 28.81 (23.51; 32.65) kg/m²: at DM – 29.12 (24.48; 33.35); without DM – 27.92 (22.85; 31.26). The presence of DM didn’t show any differences in eating behavior (DEBQ questionnaire) in contrast to BMI and gender. The emotiogenic style has become the leading one, the incentive for food intake is not hunger, but emotional discomfort in people with BMI ≥ 25 kg/m² – 48.6%; in women, in contrast to men (χ²=16.71; P <0.0001). The results of HADS scales indicate the same frequency of occurrence of depression in individuals with and without DM, in contrast to the manifestations of anxiety, which are more often recorded in diabetes (χ²=3.96; P <0.05). We have determined a direct correlation between the frequency of occurrence of clinically significant anxiety with the emotiogenic type of eating behavior in women with overweight or obesity (rS =0.49; P <0.05) Also there has been determined the absence of correlation between the psychoemotional status of men and types of eating behavior according to BMI and presence of DM type 2. Both individuals with DM (84.62%) and without DM (83.17%) demonstrated high stress tolerance (scales of assessment of social adaptation by T. Holmes, R. Reich), but more often it was noted in individuals with DM (χ²=4.20; P=0.04), which indicates psycho-emotional stress and difficulties in overcoming negative psychological situations. The non-alexithymic type of personality (Toronto alexithymia scale) was noted in 81.58% of cases in persons without DM and in 79.23% with DM (P> 0.05). The alexitimic personality type was more often noted at BMI ≥ 25 kg/m² (χ²=6.28; P=0.01) and showed a direct correlation with the clinical manifestations of anxiety (rS =0.34; P <0.042). The study demonstrated that overweight people, even without DM, are in a state of disadaptation and psychoemotional stress, which may be a risk factor for the development of psychosomatic diseases and DM.